Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product

With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product potential addressing a target that has clinical and regulatory validation from a recently approved Novartis drug. Vidya’s molecule is a next-generation drug that could have advantages over Novartis’s pill. The post Processa Acquisition Lands Immunology Drug That Could Rival…

Read More

Smart Toilet Sensor Startup Is Flush with $10M Funding

Throne Science — a startup selling an AI-powered toilet camera that tracks gut health, hydration and urinary function — closed a $10 million Series A funding round. CEO Scott Hickle said the goal is to become a “smoke detector for colorectal cancer,” filling a monitoring gap he noted the wearables industry has largely ignored. The…

Read More